Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06989658 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's Disease

Study acronym: RE-SEE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jun 2025 to Oct 2025
    • Study sites: 0 to 1
    • Primary and study completion dates: Aug 2027 to Feb 2028
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Oculometry is becoming increasingly popular in fields such as enhanced reality and healthcare, but remains limited by complex devices that are poorly adapted to the needs of users, particularly the visually impaired. This research proposes to explore a smart contact lens (SCL)-based system to overcome these limitations, particularly for people with central visual deficits such as Stargardt's disease.
Trial Details
NCT Number NCT06989658
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Collaborators: Ecole Nationale Supérieure Mines - Télécom Atlantique Bretagne Pays de la Loire., StreetLab Vision
Conditions
(from sponsor)		 Stargardt Disease
Related terms Stargardt Disease
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov